Maternal hypercholesterolemia and treatment during pregnancy influence thelong-term progression of atherosclerosis in offspring of rabbits

Citation
W. Palinski et al., Maternal hypercholesterolemia and treatment during pregnancy influence thelong-term progression of atherosclerosis in offspring of rabbits, CIRCUL RES, 89(11), 2001, pp. 991-996
Citations number
28
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
CIRCULATION RESEARCH
ISSN journal
00097330 → ACNP
Volume
89
Issue
11
Year of publication
2001
Pages
991 - 996
Database
ISI
SICI code
0009-7330(20011123)89:11<991:MHATDP>2.0.ZU;2-G
Abstract
Maternal hypercholesterolemia during pregnancy is associated with enhanced fatty streak formation in human fetuses and faster progression of atheroscl erosis during childhood even under normocholesterolemic conditions. A causa l role of maternal hypercholesterolemia in lesion formation during fetal de velopment has previously been established in rabbits. The same experimental model is now used to establish that maternal hypercholesterolemia or ensui ng pathogenic events in fetal arteries enhance atherogenesis later in life. Five groups of rabbit mothers were fed chow, cholesterol-enriched chow, or cholesterol-enriched chow plus 1000 lU vitamin E, 3% cholestyramine, or bo th during pregnancy. Offspring of all groups (n = 136) were fed a mildly hy percholesterolemic diet for up to a year and had similar cholesterol levels . Aortic lesion sizes and lipid peroxidation products in plasma and lesions in offspring were determined at birth, 6 months, or 12 months. Lesion prog ression in offspring of hypercholesterolemic mothers was greater than in al l other groups. At each time point, offspring of hypercholesterolemic mothe rs had 1.5- to 3-fold larger lesions than offspring of normocholesterolemic mothers (P<0.01), with the greatest absolute differences at 12 months. Mat ernal treatment reduced lesions by 19% to 53%, compared with offspring of u ntreated hypercholesterolemic mothers (P<0.01), with the greatest effect in the vitamin E groups. At 12 months, lesions in offspring of all vitamin E and cholestyramine-treated mothers were similar to those of normocholestero lemic mothers. Lipid peroxidation end-products in lesions and plasma showed analogous differences between groups as lesions (P<0.01). Thus, pathogenic programming in utero increases the susceptibility to atherogenic risk fact ors later in life and maternal intervention with cholesterol-lowering drugs or antioxidants reduce postnatal lipid peroxidation and atherosclerosis in their offspring.